Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Rosewind CORP | 36,102 | reported | 03 Oct 2025 | tx 23+141,000−2,500 |
| Evoke Pharma Inc | 0 | reported | 17 Dec 2025 | tx 4+6,988−6,988 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Dec 2025 | OTHER | Evoke Pharma Inc | 5,833 | — | deriv |
| 17 Dec 2025 | OTHER | Evoke Pharma Inc | 1,155 | — | deriv |
| 03 Oct 2025 | GRANT_AWARD | Rosewind CORP | 12,500 | 0.00 USD | |
| 21 May 2025 | GRANT_AWARD | Evoke Pharma Inc | 1,155 | 0.00 USD | deriv |
| 31 Mar 2025 | EXERCISE | Rosewind CORP | 209 | — | |
| 31 Mar 2025 | EXERCISE | Rosewind CORP | 209 | 0.00 USD | deriv |
| 20 Feb 2025 | GRANT_AWARD | Evoke Pharma Inc | 5,833 | 0.00 USD | deriv |
| 31 Dec 2024 | EXERCISE | Rosewind CORP | 208 | — | |
| 31 Dec 2024 | EXERCISE | Rosewind CORP | 208 | 0.00 USD | deriv |
| 06 Nov 2024 | GRANT_AWARD | Rosewind CORP | 7,000 | 0.00 USD | deriv |
| 30 Sept 2024 | EXERCISE | Rosewind CORP | 209 | — | |
| 30 Sept 2024 | EXERCISE | Rosewind CORP | 209 | 0.00 USD | deriv |
| 30 Jun 2024 | EXERCISE | Rosewind CORP | 208 | — | |
| 30 Jun 2024 | EXERCISE | Rosewind CORP | 208 | 0.00 USD | deriv |
| 31 Mar 2024 | EXERCISE | Rosewind CORP | 208 | — | |
| 31 Mar 2024 | EXERCISE | Rosewind CORP | 208 | 0.00 USD | deriv |
| 31 Dec 2023 | EXERCISE | Rosewind CORP | 209 | — | |
| 31 Dec 2023 | EXERCISE | Rosewind CORP | 209 | 0.00 USD | deriv |
| 30 Sept 2023 | EXERCISE | Rosewind CORP | 208 | — | |
| 30 Sept 2023 | EXERCISE | Rosewind CORP | 208 | 0.00 USD | deriv |
| 11 Aug 2023 | GRANT_AWARD | Rosewind CORP | 7,000 | 0.00 USD | deriv |
| 30 Jun 2023 | EXERCISE | Rosewind CORP | 208 | — | |
| 30 Jun 2023 | EXERCISE | Rosewind CORP | 208 | 0.00 USD | deriv |
| 16 Jun 2023 | PURCHASE | Rosewind CORP | 12,000 | 1.87 USD | |
| 25 Apr 2023 | EXERCISE | Rosewind CORP | 833 | 0.00 USD |